Winmark Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 12-12-2024
- Paid Up Capital ₹ 0.85 M
as on 12-12-2024
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -29.86%
(FY 2020)
- Profit -42.72%
(FY 2020)
- Ebitda 76.28%
(FY 2020)
- Net Worth 13.22%
(FY 2020)
- Total Assets -53.72%
(FY 2020)
About Winmark Life Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.85 M, as per Ministry of Corporate Affairs (MCA) records.
Ramakrishna Chamala and Nathi Nagalaxmi serve as directors at the Company.
- CIN/LLPIN
U51900TG2015PTC098475
- Company No.
098475
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Apr 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Winmark Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramakrishna Chamala  | Director | 15-Apr-2015 | Current |
| Nathi Nagalaxmi | Additional Director | 01-Jul-2016 | Current |
Financial Performance of Winmark Life Sciences.
Winmark Life Sciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 29.86% decrease. The company also saw a substantial fall in profitability, with a 42.72% decrease in profit. The company's net worth Soared by an impressive increase of 13.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Winmark Life Sciences?
In 2019, Winmark Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Winmark Life Sciences?
Unlock and access historical data on people associated with Winmark Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Winmark Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Winmark Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
